Get App
Celestial Biolabs > Company History > Pharmaceuticals > Company History of Celestial Biolabs - BSE: 532871, NSE: CELESTIAL

Celestial Biolabs

BSE: 532871|NSE: CELESTIAL|ISIN: INE221I01017|SECTOR: Pharmaceuticals
Jan 20, 16:00
0.13 (4.73%)
VOLUME 5,557
Jan 23, 12:10
-0.1 (-3.64%)
Company History - Celestial Biolabs
CELESTIAL LABS LIMITED was incorporated as a Private Limited Company
 on November 19, 1997 
 as Celestial Technologies Private Limited. The subscribers to the
 memorandum were Mr. Rajani Kanth 
 Katragadda and Mr. Vijay Marur. The company was later converted into
 a Public Limited Company under 
 the name Celestial Technologies Limited on December 6, 1999 and has
 been subsequently renamed 
 as CELESTIAL LABS LIMITED effective from February 13, 2004. The
 present promoter of the company 
 is Mr. Aditya Narayan Singh. The Original promoters sold their
 holding to the present promoter on 7.11.1998. 
 CELESTIAL LABS LIMITED is a Hyderabad based ISO 9001-2000 certified
 company. It has been providing 
 customized enterprise solutions, bioinformatics services and also
 involved in development of 
 biopharmaceuticals and industrial enzymes. CELESTIAL LABS is in
 contact with Centre for Cellular & 
 Molecular Biology (CCMB) under the aegis of Council for Scientific
 and Industrial Research, Ministry of 
 Science and Technology, Government of India and Indian Institute of
 Chemical Technology (IICT), premier 
 chemical and Biological Institutions in Hyderabad to work on
 collaborative research projects to be funded by 
 Department of Science and Technology New Delhi. The in-house research
 and development centre of 
 CELESTIAL LABS is recognized by the Department for Scientific and
 Industrial Research, Ministry of Science 
 and Technology, New Delhi.
 Major Events in the history of the Company are given below: 
 Year 	Event 	
 1997 	Incorporation of Company 	
 1999 	Conversion of Private Limited Company to Public Limited Company
 and Change of Management . 	
 2004 	ISO Certification 	
 2004 	Development of a denovo drug design tool CELSUITE 	
 2004 	Change of name from Celestial Technologies Limited to Celestial
 Labs Limited 	
 2004 	Developed a bio-molecule to treat Vitiligo 	
 2005 	Designed a bio-molecule to treat multi cancer 	
 The company has developed a de novo drug design tool CELSUITE to aid
 the pharma industry in 
 discovering new molecules for curing different diseases. This tool
 will enable the company not only to 
 design new molecules for its own purpose but also to provide the
 bio-informatics services to the various 
 pharma and biotech companies. This tool has filed for protection of
 the IPR under the Copy Right Act vide 
 Dairy no 147-151 /05 on 20.06.2005 to the department. 
 Based on the company's in silico expertise (applying bioinformatics
 tools), the company has developed 
 therapeutic molecules to treat Leucoderma and multiple cancers. The
 cloned molecules are being subjected 
 for purification by the wet lab procedures at the company's
 collaborative Institute, Department of Microbiology, 
 Osmania University, Hyderabad. 
 In the industrial biotechnology area, the company has signed the
 technology transfer agreement with IMTECH 
 Chandigarh (a very reputed Council of Scientific & Industrial
 Research organization) for the manufacture of two 
 industrial enzymes - alpha Amylase and alkaline Protease. Initially
 these would be marketed in India and later 
 The company has initiated setting up of a biotechnology facility to
 develop its drug molecules and manufacture 
 industrial enzymes. This facility would also include the research
 laboratories for carrying out further R & D 
 activities to develop new related products for reducing wrinkles /
 stretch marks and acceleration of wound 
 healing from the same chemical structure of vitiligo. The proposed
 facility will be set up at Shapoorji Pallonji 
 Biotech Park in Genome Valley at Hyderabad in Andhra Pradesh. 
 The company has also plans to cater to the laboratory process
 outsourcing by using innovative platform 
 technologies/services in the field of analytical laboratory and
 bio-computational systems. The company is 
 positioned to drive innovations and support activities in post genome
 advancements via clinical trials (CT) 
 and laboratory process outsourcing (LPO) to be a significant player
 in personalized medicine in select disease 
 - Celestial Labs Ltd has informed that the Board of Directors of the
 Company by a resolution passed by circulation has appointed Mr.
 Subhash C Srivastava as an Additional Director of the Company w.e.f.
 April 15, 2009.
 -Company has changed its name from Celestial Labs Ltd. to Celestial
 Biolabs Ltd.  
 --Registered Office of the Company has been shifted from Plot # 231A,
 MLA Colony, Road # 12, Banjara Hills, Hyderabad- 500034 to Plot No.
 59, Road No. 12, APIIC Tech Park, IDA Nacharam, Hyderabad - 500076
 -Celestial Biolabs Ltd Launching of New Product - Cadalmin GAe
 -Celestial Biolabs Ltd Hyderabad has launched Cadalmin Gae, a marine
 derived, developed, formulated clinically tested and patented natural
 product to treat arthritis (all kinds of joint pain).
 -Celestial Biolabs launches new drug to treat arthritis
 -Celestial To Launch Patented Anti-Diabetic Product.
 -Drug maker Celestial Biolabs Ltd has successfully completed
 pre-clinical study on mouse for finding out toxicity and efficacy for
 Herbal Biovita, a health drink.
Source : Dion Global Solutions Limited
Quick Links for Celestial Biolabs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.